Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is one of the most common inherited cardiomyopathies, but as many as 85% of people with the condition have not been diagnosed. Missing the presence of HCM could lead to significant morbidity, most severely sudden cardiac death.

Hypertrophic Cardiomyopathy

Skilled echocardiography and image interpretation is critical to diagnosing HCM and distinguishing it from other cardiac conditions. It is also necessary in guiding certain treatment options, such as septal reduction therapy (SRT) and mitral valve repair. Physicians and sonographers can struggle to recognize the specific clinical signs and symptoms that indicate the need for echocardiographic evaluation in patients suspected of having HCM. Further, there is a lack of consistent use and understanding of advanced echocardiographic modalities among clinicians, which results in suboptimal assessments of HCM. To address this and other gaps, ASE is leading innovation, inclusion and integration in HCM by providing education and conducting Forums that bring together key group leaders in the clinical community with the goal of improving patient care.

Goal Directed Valsalva Education Series

Elevate your diagnostic accuracy by mastering the nuances of the Valsalva maneuver in echocardiography. This microlesson series explores traditional instructed Valsalva versus the Goal Directed maneuver, providing "tips and tricks" to overcome common pitfalls.

We will examine the physiological phases of Valsalva and will dive into how Valsalva-induced hemodynamic shifts serve as a vital tool for both initial diagnosis and therapeutic follow-up.

YouTube video
Goal Directed Valsalva Education Series
HCM-Stats

1 - Familial hypertrophic cardiomyopathy. The Medline Plus website. Available at: https://medlineplus.gov/genetics/condition/familial-hypertrophiccardiomyopathy/#
frequency. Accessed on July 26, 2023.

2 - Hypertrophic cardiomyopathy (HCM). The American Heart Association website. Available at: https://www.heart.org/en/health-topics/
cardiomyopathy/what-is-cardiomyopathy-in-adults/hypertrophic-cardiomyopathy. Accessed on July 26, 2023.

ASE Offers a Hypertrophic Cardiomyopathy Certificate of Completion

Resources

HCM-Poster-0

The Role of Echocardiography in Hypertrophic Cardiomyopathy Poster

Poster Resource

HCM-BMS-poster

A Practical Approach to Echocardiographic Imaging in Patients with Hypertrophic Cardiomyopathy

Developed with support from Bristol Myers Squibb.

YouTube video

Microlessons in Echocardiography and HCM Series

Watch the Microlesson in Echocardiography and HCM Series Playlist on ASE’s YouTube Channel.

ASE thanks the following faculty members for their contributions to this microlesson content:
Ted Abraham, MD, FASE, Steven Lester, MD, FASE, Carol Mitchell, PhD, RDMS, RDCS, RVT, RT(R), ACS, FASE, Dermot Phelan, MD, PhD, FASE, Madeline Jankowski, BS, ACS, RDCS, FASE

Articles

JASE - card@2x

A Practical Approach to Echocardiographic Imaging in Patients with Hypertrophic Cardiomyopathy

JASE Article

ASE Guideline on Multimodality Cardiovascular Imaging of Patients with HCM Updated June 2022

Guideline

ECHO- card@2x

ASE 2024 HCM Forum Takes a Deep Dive into the Nuances of Hypertrophic Cardiomyopathy

Echo Magazine Article

Webinars On-Demand

ASE logo

Hypertrophic Cardiomyopathy (HCM) State-of-the-Art: Comprehensive Echocardiographic Evaluation – Part 1

This on-demand webinar, FREE for ASE Members and Nonmembers, provides an overview on the utility of echocardiography in the diagnosis and prognosis of HCM. In addition, the speakers outline identifying markers of HCM and provide guidance for sonographers and echo reviewers on what elements of the exam are most important in echo reporting. You can claim 1.0 AMA PRA Category 1 Credit™.

ASE On-Demand Webinars

ECHO- card@2x

Hypertrophic Cardiomyopathy State-of-the-Art: Comprehensive Echocardiographic Evaluation – Part 2

This webinar, FREE for ASE Members and Nonmembers, addresses echocardiographic guidance for septal reduction in HCM, risk stratification for sudden cardiac death in HCM, and includes a case-based presentation on challenging HCM cases and clinical conundrums. You can claim 1.0 AMA PRA Category 1 Credit™.

ASE On-Demand Webinars